Inspection Stats Show Firms Grappling With Complaint Handling
This article was originally published in The Gray Sheet
Executive SummaryComplaint handling continues to confound some device firms, with 11% of inspection observations in 2005 noting violations of that section of the Quality System Regulation (QSR), according to FDA statistics
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.